Keyphrases
Activating Transcription Factor 2 (ATF2)
14%
Cancer Mortality
14%
Cancer-specific Survival
28%
Chemotherapy
14%
Clinical Trials
14%
Distant Disease
14%
Distant Metastasis
100%
Distant Recurrence
14%
E6 Gene
100%
Epidermal Growth Factor Receptor
14%
Expression Level
28%
Favorable Prognosis
14%
Gene Expression
100%
Gene Expression Level
28%
Gene Expression Profiling
14%
Gene Set Enrichment Analysis
14%
Growth Factor Signaling Pathways
14%
High-risk Human Papillomavirus (HR-HPV)
85%
Kaplan-Meier Survival Analysis
14%
Multi-institutional
14%
Multivariate Regression Model
14%
Nodal Stage
14%
Non-recurring
14%
Novel Biomarkers
14%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
100%
Patient's Will
14%
Poor Survival
100%
Primary Tumor
14%
Prognostic Biomarker
14%
Prospective Clinical Trial
14%
Quantitative PCR
14%
Receiver Operating Characteristic Analysis
14%
Recurrence-free Survival
28%
Recurrent Disease
14%
Recurring
14%
Risk Stratification
14%
RNA Sequencing (RNA-seq)
14%
RNA-seq Analysis
14%
Smoking Status
14%
Statistical Significance
14%
Transforming Growth Factor-β
14%
Treatment Standards
14%
Tumor
14%
Tumor Specimens
14%
Validation Cohort
14%
Medicine and Dentistry
Activating Transcription Factor 2
14%
Biological Marker
28%
Cancer Growth Factor
14%
Cancer Specific Survival
28%
Cell Signaling Pathway
14%
Clinical Trial
28%
Distant Metastasis
100%
Epidermal Growth Factor Receptor
14%
Gene Expression
100%
Gene Expression Profiling
14%
Genome-Wide Analysis of Gene Expression
14%
Malignant Neoplasm
14%
Neoplasm
14%
Oropharynx Squamous Cell Carcinoma
100%
Primary Tumor
14%
Protein P53
14%
Real-Time Polymerase Chain Reaction
14%
Recurrence Free Survival
28%
Recurrent Disease
28%
RNA Sequence
28%
Survival Analysis
14%
Wart Virus
85%